Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on May 31, 2025
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
May 31, 2025
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a clinically meaningful increase in median overall survival (10.1 months vs 7.2 months; log-rank p=0.01) in previously untreated patients with metastatic pancreatic ductal …
PlanChecker AI Launches with the Goal to Rewire the Infrastructure of Real Estate Development
EIN Presswire
·
May 31, 2025
LOS ANGELES, CA, UNITED STATES, May 31, 2025 /EINPresswire.com/ -- Co-founded by veteran real estate developer Matthew Raanan and senior software engineer Justine Raanan, the Los Angeles-based startup PlanCheker AI launches as an innovative compliance …
Trade 350 App: This Trade 350 App Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval
GlobeNewswire
·
May 31, 2025
New York City, NY, May 31, 2025 (GLOBE NEWSWIRE) -- Introduction In the crowded world of online trading platforms, separating legitimate services from elaborate scams can be a daunting task. Trade 350 App has emerged as one of the buzziest names in 2025, …
Starscope: Does Starscope Monocular Really Work for Stargazing & Hiking? Read Full Starscope Monocular Telescope Consumer Report!
GlobeNewswire
·
May 31, 2025
San Diego, CA, May 31, 2025 (GLOBE NEWSWIRE) -- Introduction: Why the Starscope Monocular Is Gaining Popularity in 2025 Whether you're a nature lover, hiker, hunter, or stargazer, having the right optical gear can make or break your outdoor experience. In …
Robex gibt Abschluss des Börsengangs bekannt
GlobeNewswire
·
May 31, 2025
STADT QUÉBEC, May 31, 2025 (GLOBE NEWSWIRE) -- Der westafrikanische Goldproduzent und -erschließer Robex Resources Inc („Robex“ oder das „Unternehmen“) (TSX-V: RBX) freut sich bekannt zu geben, dass das Unternehmen den Börsengang an der Australian …
Robex annonce la finalisation de son introduction en bourse
GlobeNewswire
·
May 31, 2025
QUÉBEC, 31 mai 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (« Robex » ou la « Société ») (TSX-V : RBX), producteur et développeur aurifère ouest-africain, a le plaisir d’annoncer le succès de son introduction sur la bourse australienne (« ASX ») avec 38 …
JAMining Expands FCA-Regulated Cloud Mining Services Amid Surging Crypto Market Activity
GlobeNewswire
·
May 31, 2025
Image by JAMining LONDON, May 31, 2025 (GLOBE NEWSWIRE) -- JAMining, a UK-based cloud mining provider regulated by the Financial Conduct Authority (FCA), has announced a major expansion of its services. This strategic move comes amid a surge in global …
PAIRMiner Makes Bitcoin Mining More Accessible Amid Market Surge
GlobeNewswire
·
May 31, 2025
Image by PAIRMiner STUTTGART, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- As Bitcoin prices rise past key resistance levels, investor interest in digital assets is once again on the upswing. PAIRMiner, a cloud-based cryptocurrency mining platform, is helping …
Silicon Valley Hair Institute Announces Updated Content on Eyebrow Transplantation
EIN Presswire
·
May 31, 2025
Silicon Valley Hair Institute is excited to announce updated content for eyebrow transplantation. SAN FRANCISCO, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Silicon Valley Hair Institute, the Bay Area leader in hair transplant and replacement …
Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
GlobeNewswire
·
May 31, 2025
Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
May 31, 2025
Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
GlobeNewswire
·
May 31, 2025
Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …
Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec un adénocarcinome pancréatique métastatique traités par Onivyde®
GlobeNewswire
·
May 31, 2025
L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
GlobeNewswire
·
May 31, 2025
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable tolerability and promising clinical activity with ongoing deep and durable objective responses up to >2.5 years …
ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025
GlobeNewswire
·
May 31, 2025
– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) – – Padeliporfin VTP treatment continues to be safe and well-tolerated, …
Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025
GlobeNewswire
·
May 31, 2025
Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
GlobeNewswire
·
May 31, 2025
26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …
Online Crypto Casinos: All iGaming Reveals the Top Sites for Crypto Gamblers in 2025
GlobeNewswire
·
May 31, 2025
Jersey City, NJ, May 31, 2025 (GLOBE NEWSWIRE) -- - These days, the internet is flooded with crypto casinos all claiming to offer the best games, biggest bonuses, and fastest payouts. But finding a truly reputable crypto casino isn’t about luck- it’s …
Free Psychic Medium Readings | Chat with Real Mediums Online – Special 2025 Announcement
GlobeNewswire
·
May 31, 2025
San Francisco, CA, May 31, 2025 (GLOBE NEWSWIRE) -- - In today's digital age, connecting with a psychic medium is easier and more accessible than ever. Whether you're seeking comfort after a loss, clarity on life’s deeper questions, or simply curious about …
PAIRMiner Launches $150 Cloud Mining Incentive as Institutional Bitcoin Holdings Reach Historic Levels
GlobeNewswire
·
May 31, 2025
Amid a surge in institutional Bitcoin investments, PAIRMiner introduces a free cloud mining offer to make crypto access easier for everyday users. Image by PAIRMiner LOS ANGELES, May 31, 2025 (GLOBE NEWSWIRE) -- Cloud mining platform PAIRMiner today …